AURKA and neuroblastoma: AURKA stabilises MYCN via a direct interaction with a protein binding site flanking MYCN's MBI sequence (107), this stabilisation of MYCN exacerbates its oncogenic functions, and prevents differentiation of neuroblasts in MYCN-driven neuroblastoma (NB) cell lines, leading to aberrant proliferation (108).